ISSCR News
The Future Is Now
We’ve seen some extraordinary stem cell advances reaching the clinic. A recent clinical trial could have a significant impact on patients with Type 1 diabetes. Advances in cell therapy for the treatment of Parkinson’s disease, and a stem cell-derived model that has enabled researchers to identify drug candidates that may slow dry age-related macular degeneration (AMD). These are only a few of the potential ways stem cell science is positioned to make significant impact on the treatment of devastating diseases.
Member Spotlight: Ujang Purnama
“What I value most about being an ISSCR member is the annual meeting. I really like interacting and having conversations with people in the stem cell community to discuss my work”.
Boosting Function and Survival of Stem Cell-derived Pancreatic Cells by Genetic Engineering
Recent advances in the transplantation of stem cell-derived insulin-producing beta cells (SC-beta cells) to treat type 1 diabetes (T1D) has generated considerable interest and excitement. A major obstacle to the long-term survival and functioning of SC-beta cells is their vulnerability to stress or attacks from the immune system, which can ultimately lead to malfunction or death of the cells. A recent study published in the journal Stem Cell Reports has identified new ways to potentially enhance the SC-beta cell survivability through genetic manipulation of the cells.
The ISSCR Comments on Draft Guidance from FDA - Real-World Data: Assessing Registries to Support Regulatory Decision-Making for Drug and Biological Products
The ISSCR shared comments on draft guidance from the FDA's Center for Biologics Evaluation and Research (CBER) (Docket No. FDA2021-D-1146) Real-World Data: Assessing Registries to Support Regulatory Decision Making for Drug and Biological Products.
The ISSCR Launches Standards Initiative for Pluripotent Stem Cell Research
Universally accepted characterization standards for stem cell research are needed to improve the rigor and reproducibility of stem cell research. Standards set researchers up for success, ensure rigor in preclinical research, and ultimately strengthen the pipeline of therapies for patients. As the foremost international stem cell research society with a reputation for scientific and ethical rigor, the ISSCR is uniquely positioned to develop and propose research standards that can be widely adopted worldwide.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .